跳至主要内容
临床试验/NCT02990442
NCT02990442Unknown不适用

The Effect of Rapid Transcranial Magnetic Stimulation (rTMS) on Aggression in Forensic Patients

St. Joseph's Healthcare Hamilton2 个研究点 分布在 1 个国家目标入组 10 人开始时间: 2017年11月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
入组人数
10
试验地点
2
主要终点
Change in Aggressive Incident Scale (AIS)

研究概览

简要总结

Forensic patients will undergo 30 rTMS treatments, once per day each business day using a 1Hz frequency at the right dorso-lateral pre frontal cortex, located using modified BEAM F3. Patients will be assessed before and after the study with a battery of assessments and using 2 computer tasks: a ball passing task, and the Point Subtraction Aggression Paradigm (PSAP). The investigators will also monitor and record aggressive incidents that take place on the unit.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • are voluntary and competent to consent to treatment
  • are a current Forensics inpatient at St. Joseph's West 5th Campus
  • demonstrate aggressive behavior as confirmed by a psychologist or psychiatrist including verbal and physical aggression
  • are between the ages of 18 and 65
  • have had no changes in dose or initiation of any psychotropic medication in the 4 weeks prior to motor threshold
  • are willing and able to adhere to the treatment schedule
  • pass the TMS adult Safety-Screening (TASS) Questionnaire

排除标准

  • Withdraw consent to participate in the study
  • fail the TASS Safety Screening Questionnaire
  • have a concomitant major unstable medical illness, cardiac pacemaker or implanted medication pump, or a significant history of seizures
  • have active suicidal intent
  • are pregnant as confirmed by pregnancy test completed as part of pre-study screening
  • have any significant neurological disorder or insult including, but not limited to: any condition likely to be associated with increased intracranial pressure, space occupying brain lesion, any significant history of seizure except those therapeutically induced by electroconvulsive therapy (ECT), cerebral aneurysm, Parkinson's disease, Huntington's chorea, multiple sclerosis
  • have an intracranial implant (e.g., aneurysm clips, shunts, stimulators, cochlear implants, or electrodes) or any other metal object within or near the head, excluding the mouth, that cannot be safely removed
  • currently (or in the last 4 weeks) take more than lorazepam 2 mg daily (or equivalent) due to seizure risk or any dose of an anticonvulsant due to the potential to limit rTMS efficacy
  • non-correctable clinically significant sensory impairment (i.e., cannot hear well enough to cooperate with interview).

研究组 & 干预措施

rTMS

Experimental

treatment with repetitive transcranial magnetic stimulation for 30 days

干预措施: rTMS (Device)

结局指标

主要结局

Change in Aggressive Incident Scale (AIS)

时间窗: 30 days

ranking scale of aggressive incidents

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Gary Chaimowitz

Head of Forensics

St. Joseph's Healthcare Hamilton

研究点 (2)

Loading locations...

相似试验